Hyperkalemia

Plant-Based Diet Not Associated With Serious Hyperkalemia in CKD

Publish Date May 21, 2020

Personalized nutritional counseling appears essential in maintaining a low-protein diet.

Hyperkalemia Management Varies in the US

Publish Date May 21, 2020

No dominant treatment strategy was observed among 11 nephrology practices across the United States.

RAAS Discontinuation in Pediatric Advanced CKD Leads to Kidney Function Decline

Publish Date April 27, 2020

In a propensity score-matched analysis, children who discontinued renin-angiotensin-aldosterone system inhibition (RAASi) had significantly faster eGFR decline compared with those who continued RAASi.

Potassium Binder Dosing Regimen for HD Patients Receives FDA Approval

Publish Date April 27, 2020

In its first label update since sodium zirconium cyclosilicate was approved in 2018, FDA has a dosage regimen specifically to treat hyperkalemia in stable hemodialysis patients.

Review: MRAs May Be Safe, Effective in Select Dialysis Cases

Publish Date April 15, 2020

Case series and retrospective studies have shed some light on the safety and potential clinical and cardiovascular effects of MRAs in patients with end-stage kidney disease with and without heart failure.

Predictors of Cotrimoxazole-Associated AKI, Hyperkalemia Identified

Publish Date April 7, 2020

Investigators newly identified pre-existing cardiac disorders in cotrimoxazole users as an AKI risk factor.

Potassium Binder May Be Useful in Treating Emergency Hyperkalemia

Publish Date April 3, 2020

Preliminary research suggests sodium zirconium cyclosilicate may be an effective adjunct therapy to insulin and glucose in emergent hyperkalemia.

RAS Blockade Discontinuation Tied With Death, MACE in Advanced Kidney Disease

Publish Date March 10, 2020

Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.

Managing Electrolyte Imbalances in Kidney Transplant Recipients

Publish Date March 10, 2020

Hyperkalemia, hypomagnesemia, and hyperparathyroidism commonly persist after kidney transplant surgery.

Potassium Binder Found Effective Regardless of CKD Stage

Publish Date February 24, 2020

In a study, sodium zirconium cyclosilicatesimilarly maintained normokalemia in nondialysis CKD patients with an eGFR above and below a threshold of 30 mL/min/1.73 m2.